Impact of tobacco use on postoperative complications following partial nephrectomy.

IF 2.4 3区 医学 Q3 ONCOLOGY
José Ignacio Nolazco, Kevin R Melnick, Jeffrey Che-Wei Chang, Madhur Nayan, Yuzhe Tang, Dejan K Filipas, Krzysztof Przewoźniak, Stênio de Cássio Zequi, Leonardo O Reis, Khalid Y Alkhatib, Michael S Leapman, David E Hinojosa-Gonzalez, Marc A Bjurlin, Matthew Mossanen, Benjamin I Chung, Steven Lee Chang
{"title":"Impact of tobacco use on postoperative complications following partial nephrectomy.","authors":"José Ignacio Nolazco, Kevin R Melnick, Jeffrey Che-Wei Chang, Madhur Nayan, Yuzhe Tang, Dejan K Filipas, Krzysztof Przewoźniak, Stênio de Cássio Zequi, Leonardo O Reis, Khalid Y Alkhatib, Michael S Leapman, David E Hinojosa-Gonzalez, Marc A Bjurlin, Matthew Mossanen, Benjamin I Chung, Steven Lee Chang","doi":"10.1016/j.urolonc.2025.02.020","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>While tobacco use has been associated with postoperative surgical complications, its specific impact on postoperative outcomes following partial nephrectomy remains incompletely understood. Therefore, we aim to investigate the association between tobacco use and the incidence and severity of 90-day postoperative complications in patients who underwent partial nephrectomy.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted using the Premier Healthcare Database (2010-2019). Our primary outcome was the occurrence of 90-day postoperative complications, classified according to the Dindo-Clavien system. Multinomial logistic regression, adjusted for confounders, estimated the association between tobacco use and the risk of postoperative complications, including 90-day mortality. Predicted probabilities of postoperative complications were calculated from the regression analysis.</p><p><strong>Results: </strong>The study included 44,392 patients (median age 56.3; 66.1% males) who underwent elective partial nephrectomy. Among them, 16,048 (36.15%) were tobacco users. Tobacco users were generally younger, less frequently married, predominantly of white ethnicity, and had elevated Charlson Comorbidity Index scores as compared to nonusers. Multinomial logistic regression revealed that tobacco use was significantly associated with increased odds of 90-day postoperative minor complications (OR 1.19, 95% CI 1.14-1.24), major complications (OR 1.41, 95% CI 1.31-1.52), and mortality (OR 1.5, 95% CI 1.01-2.24).</p><p><strong>Conclusions: </strong>In our cohort, tobacco use significantly increased the risk of minor and major postoperative complications, as well as mortality, in patients undergoing partial nephrectomy. These findings emphasize the importance of tailored preoperative smoking cessation programs to mitigate these risks.</p>","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2025.02.020","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: While tobacco use has been associated with postoperative surgical complications, its specific impact on postoperative outcomes following partial nephrectomy remains incompletely understood. Therefore, we aim to investigate the association between tobacco use and the incidence and severity of 90-day postoperative complications in patients who underwent partial nephrectomy.

Materials and methods: A cross-sectional study was conducted using the Premier Healthcare Database (2010-2019). Our primary outcome was the occurrence of 90-day postoperative complications, classified according to the Dindo-Clavien system. Multinomial logistic regression, adjusted for confounders, estimated the association between tobacco use and the risk of postoperative complications, including 90-day mortality. Predicted probabilities of postoperative complications were calculated from the regression analysis.

Results: The study included 44,392 patients (median age 56.3; 66.1% males) who underwent elective partial nephrectomy. Among them, 16,048 (36.15%) were tobacco users. Tobacco users were generally younger, less frequently married, predominantly of white ethnicity, and had elevated Charlson Comorbidity Index scores as compared to nonusers. Multinomial logistic regression revealed that tobacco use was significantly associated with increased odds of 90-day postoperative minor complications (OR 1.19, 95% CI 1.14-1.24), major complications (OR 1.41, 95% CI 1.31-1.52), and mortality (OR 1.5, 95% CI 1.01-2.24).

Conclusions: In our cohort, tobacco use significantly increased the risk of minor and major postoperative complications, as well as mortality, in patients undergoing partial nephrectomy. These findings emphasize the importance of tailored preoperative smoking cessation programs to mitigate these risks.

目的:虽然烟草使用与术后手术并发症有关,但其对肾部分切除术后结果的具体影响仍不完全清楚。因此,我们旨在调查接受肾部分切除术的患者吸烟与术后 90 天并发症的发生率和严重程度之间的关系:我们使用Premier Healthcare数据库(2010-2019年)进行了一项横断面研究。我们的主要结果是术后 90 天并发症的发生率,根据 Dindo-Clavien 系统进行分类。经混杂因素调整后,多项式逻辑回归估算了吸烟与术后并发症(包括 90 天死亡率)风险之间的关系。根据回归分析计算出术后并发症的预测概率:研究纳入了44392名接受择期肾部分切除术的患者(中位年龄56.3岁;66.1%为男性)。其中有 16,048 人(36.15%)是烟草使用者。与非烟草使用者相比,烟草使用者通常更年轻,更少结婚,主要是白人,夏尔森合并症指数(Charlson Comorbidity Index)评分更高。多项式逻辑回归显示,吸烟与术后90天轻微并发症(OR 1.19,95% CI 1.14-1.24)、主要并发症(OR 1.41,95% CI 1.31-1.52)和死亡率(OR 1.5,95% CI 1.01-2.24)的几率增加显著相关:在我们的队列中,吸烟会显著增加肾部分切除术患者术后轻微和主要并发症以及死亡率的风险。这些发现强调了为减轻这些风险而制定有针对性的术前戒烟计划的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
3.70%
发文量
297
审稿时长
7.6 weeks
期刊介绍: Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信